How is the GlaxoSmithKline Pharmaceuticals Ltd. today?

The GlaxoSmithKline Pharmaceuticals Ltd. today is trading in the green, up by 1.08% at 3298.60.

How has GlaxoSmithKline Pharmaceuticals Ltd. performed historically?

The GlaxoSmithKline Pharmaceuticals Ltd. is currently trading up 1.08% on an intraday basis in the past week the index rose 9.19%. The index has been up 33.26% in the past quarter and rose 25.93% in the past year. You can view this in the overview section.

What is GlaxoSmithKline Pharmaceuticals Ltd. Annual Revenue?

GlaxoSmithKline Pharmaceuticals Ltd. Annual Revenue rose 8.92%, in the last year to ₹3,895.14 Cr. Its sector's average revenue growth for the last fiscal year was 9.94%.

What is GlaxoSmithKline Pharmaceuticals Ltd. Annual Net Profit?

GlaxoSmithKline Pharmaceuticals Ltd. Annual Net Profit rose 56.12% in the last year to ₹927.58 Cr. Its sector's average net profit growth for the last fiscal year was 35.32%.

What is GlaxoSmithKline Pharmaceuticals Ltd. Price to Earning Ratio?

GlaxoSmithKline Pharmaceuticals Ltd. Price to Earning Ratio is 60.24, higher than its sector PE ratio of 41.15.

What is GlaxoSmithKline Pharmaceuticals Ltd. Stock Price?

GlaxoSmithKline Pharmaceuticals Ltd. Stock Price rose 25.93% and outperformed its sector by 4.71% in the past year.

What is GlaxoSmithKline Pharmaceuticals Ltd. Quarterly Revenue?

GlaxoSmithKline Pharmaceuticals Ltd. Quarterly Revenue rose 4.79% YoY to ₹1,015.05 Cr. Its sector's average revenue growth YoY for the quarter was 11.75%.

What is GlaxoSmithKline Pharmaceuticals Ltd. Quarterly Net profit?

GlaxoSmithKline Pharmaceuticals Ltd. Quarterly Net profit rose 35.17% YoY to ₹262.87 Cr. Its sector's average net profit growth YoY for the quarter was 37.78%.

What is GlaxoSmithKline Pharmaceuticals Ltd. Debt to Equity Ratio?

GlaxoSmithKline Pharmaceuticals Ltd. Debt to Equity Ratio is zero as the company is debt-free.

What is GlaxoSmithKline Pharmaceuticals Ltd. Return on Equity(ROE)?

GlaxoSmithKline Pharmaceuticals Ltd. Return on Equity(ROE) for the last financial year was 47.53%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is GlaxoSmithKline Pharmaceuticals Ltd. Mutual Fund Holding?

GlaxoSmithKline Pharmaceuticals Ltd. Mutual Fund Holding increased by 0.21% in the last quarter to 5.17.

What is GlaxoSmithKline Pharmaceuticals Ltd. Promoter Share Holding?

GlaxoSmithKline Pharmaceuticals Ltd. Promoter Share Holding stayed the same in the most recent quarter at 75%.

What is GlaxoSmithKline Pharmaceuticals Ltd. Interest Coverage Ratio?

GlaxoSmithKline Pharmaceuticals Ltd. Interest Coverage Ratio is 1010.14, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).